Gyre Therapeutics: In The Company S Current Report On Form 8k Filed On October 30, 2023. Mr. Nussbaum Is Also Entering Into The Company S Standard Form Of Indemnification Agreement, A Form Of Which Was Previously Filed As, Regulation Fd Disclosure, Financial Statements And Exhibits
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameGyre Therapeutics, Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









